` NTP (Abliva AB) vs DAX Index Comparison - Alpha Spread

NTP
vs
D
DAX Index

Over the past 12 months, NTP has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +4% growth.

Stocks Performance
NTP vs DAX Index

Loading
NTP
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NTP vs DAX Index

Loading
NTP
DAX Index
Difference
www.alphaspread.com

Performance By Year
NTP vs DAX Index

Loading
NTP
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Abliva AB vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Abliva AB
Glance View

Market Cap
50.3m EUR
Industry
Biotechnology

Abliva AB is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of primary mitochondrial diseases. The company is headquartered in Lund, Skane. The company went IPO on 2008-10-03. The firm focuses on the development of novel treatments for primary mitochondrial diseases.

NTP Intrinsic Value
0.0064 EUR
Overvaluation 83%
Intrinsic Value
Price
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett